| Year |
Citation |
Score |
| 2023 |
Hlashwayo DF, Noormahomed EV, Bahule L, Benson C, Schooley RT, Sigaúque B, Barrett KE, Bila CG. Microbiological assessment reveals that Salmonella, Shigella and Campylobacter infections are widespread in HIV infected and uninfected patients with diarrhea in Mozambique. Plos Global Public Health. 3: e0001877. PMID 37216329 DOI: 10.1371/journal.pgph.0001877 |
0.349 |
|
| 2021 |
Banze L, Madureira AC, Zacarias BC, Nhacupe N, Mascaro-Lazcano C, Benson CA, Schooley RT, Noormahomed EV. Coinfection of HIV-1 with spp. and with Intestinal Parasites in Patients Attending Boane Health Center, Maputo Province, Mozambique. Ec Microbiology. 17: 3-16. PMID 36649459 |
0.308 |
|
| 2021 |
Huang LSM, Snyder EY, Schooley RT. Strategies and progress in CXCR4-targeted anti-HIV therapeutic development. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33624027 DOI: 10.1093/cid/ciab160 |
0.349 |
|
| 2020 |
Aslam S, Lampley E, Wooten D, Karris M, Benson C, Strathdee S, Schooley RT. Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States. Open Forum Infectious Diseases. 7: ofaa389. PMID 33005701 DOI: 10.1093/Ofid/Ofaa389 |
0.318 |
|
| 2020 |
Fang X, Meng Q, Zhang H, Liang B, Zhu S, Wang J, Zhang C, Huang LS, Zhang X, Schooley RT, An J, Xu Y, Huang Z. Design, synthesis, and biological characterization of a new class of symmetrical polyamine-based small molecule CXCR4 antagonists. European Journal of Medicinal Chemistry. 200: 112410. PMID 32492596 DOI: 10.1016/J.Ejmech.2020.112410 |
0.328 |
|
| 2020 |
Carrilho C, Miu C, Kim Y, Karki S, Balmaceda A, Challa B, Diamond S, Monteiro E, Marole E, Lorenzoni C, Zambujo Y, Liu YT, Schooley RT, Lin JH. p16 Expression Correlates with Invasive Ocular Surface Squamous Neoplasms in HIV-Infected Mozambicans. Ocular Oncology and Pathology. 6: 123-128. PMID 32258020 DOI: 10.1159/000502096 |
0.406 |
|
| 2019 |
Aslam S, Schooley RT. What's Old is New Again - Bacteriophage Therapy in the 21 century. Antimicrobial Agents and Chemotherapy. PMID 31685458 DOI: 10.1128/Aac.01987-19 |
0.326 |
|
| 2019 |
Beadle JR, Aldern KA, Zhang XQ, Valiaeva N, Hostetler KY, Schooley RT. Octadecyloxyethyl benzyl tenofovir: A novel tenofovir diester provides sustained intracellular levels of tenofovir diphosphate. Antiviral Research. 104614. PMID 31550449 DOI: 10.1016/J.Antiviral.2019.104614 |
0.416 |
|
| 2019 |
Boltz VF, Shao W, Bale MJ, Halvas EK, Luke B, McIntyre JA, Schooley RT, Lockman S, Currier JS, Sawe F, Hogg E, Hughes MD, Kearney MF, Coffin JM, Mellors JW. Linked dual-class HIV resistance mutations are associated with treatment failure. Jci Insight. PMID 31487271 DOI: 10.1172/Jci.Insight.130118 |
0.362 |
|
| 2019 |
Grinsztejn B, Hughes MD, Ritz J, Salata R, Mugyenyi P, Hogg E, Wieclaw L, Gross R, Godfrey C, Cardoso SW, Bukuru A, Makanga M, Faesen S, Mave V, Wangari Ndege B, ... ... Schooley RT, et al. Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study. The Lancet. Hiv. PMID 31371262 DOI: 10.1016/S2352-3018(19)30146-8 |
0.311 |
|
| 2019 |
Aslam S, Courtwright AM, Koval C, Lehman SM, Morales S, Langlais Furr CL, Rosas F, Brownstein MJ, Fackler JR, Sisson BM, Biswas B, Henry M, Luu T, Bivens BN, Hamilton T, ... ... Schooley RT, et al. Early clinical experience of bacteriophage therapy in three lung transplant recipients. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 31207123 DOI: 10.1111/Ajt.15503 |
0.331 |
|
| 2019 |
Zhu S, Zhang C, Huang LS, Zhang XQ, Xu Y, Fang X, Zhou J, Wu M, Schooley RT, Huang Z, An J. Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors. Molecules (Basel, Switzerland). 24. PMID 31013906 DOI: 10.3390/Molecules24081465 |
0.309 |
|
| 2019 |
Nir-Paz R, Gelman D, Khouri A, Sisson BM, Fackler J, Alkalay-Oren S, Khalifa L, Rimon A, Yerushalmy O, Bader R, Amit S, Coppenhagen-Glazer S, Henry M, Quinones J, Malagon F, ... ... Schooley RT, et al. Successful treatment of antibiotic resistant poly-microbial bone infection with bacteriophages and antibiotics combination. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30869755 DOI: 10.1093/Cid/Ciz222 |
0.302 |
|
| 2019 |
Aslam S, Pretorius V, Lehman SM, Morales S, Schooley RT. Novel bacteriophage therapy for treatment of left ventricular assist device infection. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. PMID 30661974 DOI: 10.1016/J.Healun.2019.01.001 |
0.338 |
|
| 2019 |
Nhatave C, Lucas G, Wate I, Sáu Z, Patel S, Noormahomed EV, Schooley RT, Taplitz R. Profile of bacterial infectious disease and antimicrobial choices in an urban hospital at Maputo, Mozambique: a prospective observational study The Lancet Global Health. 7. DOI: 10.1016/S2214-109X(19)30099-3 |
0.325 |
|
| 2019 |
Law N, Logan C, Furr C, Lehman S, Morales S, Rosas F, Gaidamaka A, Bilinsky I, Grint P, Schooley R, Aslam S. Successful Bacteriophage Therapy for Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection in a Cystic Fibrosis Patient Journal of Heart and Lung Transplantation. 38. DOI: 10.1016/J.Healun.2019.01.078 |
0.306 |
|
| 2019 |
Courtwright A, Koval C, Lehman S, Morales S, Furr C, Rosas F, Brownstein M, Fackler J, Sisson B, Biswas B, Schooley R, Aslam S. Safety and Efficacy of Bacteriophage Therapy in Lung Transplant Candidates and Recipients The Journal of Heart and Lung Transplantation. 38: S11-S12. DOI: 10.1016/J.Healun.2019.01.012 |
0.303 |
|
| 2018 |
Carlin AF, Wen J, Vizcarra EA, McCauley M, Chaillon A, Akrami K, Kim C, Ngono AE, Lara-Marquez ML, Smith DM, Glass CK, Schooley RT, Benner C, Shresta S. A longitudinal systems immunologic investigation of acute Zika virus infection in an individual infected while traveling to Caracas, Venezuela. Plos Neglected Tropical Diseases. 12: e0007053. PMID 30596671 DOI: 10.1371/Journal.Pntd.0007053 |
0.328 |
|
| 2018 |
Zhang C, Zhang H, Huang LS, Zhu S, Xu Y, Zhang XQ, Schooley RT, Yang X, Huang Z, An J. Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor. Molecules (Basel, Switzerland). 23. PMID 30463393 DOI: 10.3390/Molecules23113036 |
0.44 |
|
| 2018 |
Fowler AM, Tang WW, Young MP, Mamidi A, Viramontes KM, McCauley MD, Carlin AF, Schooley RT, Swanstrom J, Baric RS, Govero J, Diamond MS, Shresta S. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice. Cell Host & Microbe. 24: 743-750.e5. PMID 30439343 DOI: 10.1016/J.Chom.2018.09.015 |
0.324 |
|
| 2018 |
Schooley RT. The human microbiome: implications for health and disease, including HIV infection. Topics in Antiviral Medicine. 26: 75-78. PMID 30384329 |
0.34 |
|
| 2018 |
Cruz CCP, Mistro S, Mendes CMC, Schooley RT, da Silva Badaró RJ. Monitoring of Delay to Pharmacy Refill in Assessing Adherence to Antiretroviral Therapy. Journal of Pharmacy Practice. 897190018795339. PMID 30122111 DOI: 10.1177/0897190018795339 |
0.382 |
|
| 2018 |
Namazi G, Fajnzylber JM, Aga E, Bosch R, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, ... ... Schooley RT, et al. The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies. The Journal of Infectious Diseases. PMID 30085241 DOI: 10.1093/Infdis/Jiy479 |
0.391 |
|
| 2018 |
Smith D, Huynh C, Moore AJ, Frick A, Anderson C, Porrachia M, Scott B, Stous S, Schooley R, Little S, Santos A. Herd Immunity Likely Protected the Men who have Sex with Men in Recent Hepatitis A Outbreak in San Diego CA. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30052941 DOI: 10.1093/Cid/Ciy592 |
0.308 |
|
| 2018 |
LaVergne S, Hamilton T, Biswas B, Kumaraswamy M, Schooley RT, Wooten D. Phage Therapy for a Multidrug-Resistant Craniectomy Site Infection. Open Forum Infectious Diseases. 5: ofy064. PMID 29687015 DOI: 10.1093/Ofid/Ofy064 |
0.312 |
|
| 2017 |
Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrobial Agents and Chemotherapy. PMID 28807909 DOI: 10.1128/Aac.00954-17 |
0.326 |
|
| 2016 |
Logan C, Todorof K, Fiorillo SP, Campbell TB, Elder JH, Borok M, Gudza I, Gwanzura L, Ndemera B, Lochhead MJ, Benson CA, Schooley RT. Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus. Plos One. 11: e0163616. PMID 27669509 DOI: 10.1371/Journal.Pone.0163616 |
0.417 |
|
| 2016 |
Chen HW, Liu PF, Liu YT, Kuo S, Zhang XQ, Schooley RT, Rohde H, Gallo RL, Huang CM. Nasal commensal Staphylococcus epidermidis counteracts influenza virus. Scientific Reports. 6: 27870. PMID 27306590 DOI: 10.1038/Srep27870 |
0.338 |
|
| 2015 |
Cachay ER, Wyles D, Hill L, Ballard C, Torriani F, Colwell B, Kuo A, Schooley R, Mathews CW. The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care. Open Forum Infectious Diseases. 2: ofv168. PMID 26697509 DOI: 10.1093/Ofid/Ofv168 |
0.333 |
|
| 2015 |
Carlin AF, Aristizabal P, Song Q, Wang H, Paulson MS, Stamm LM, Schooley RT, Wyles DL. Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection. Hepatology (Baltimore, Md.). PMID 26147061 DOI: 10.1002/Hep.27971 |
0.305 |
|
| 2015 |
Orlov M, Smeaton LM, Kumwenda J, Hosseinipour MC, Campbell TB, Schooley RT. Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population. Plos One. 10: e0129519. PMID 26053030 DOI: 10.1371/Journal.Pone.0129519 |
0.659 |
|
| 2015 |
Givens M, Weaver A, Bickman S, Logan C, Noormahomed EV, Patel S, Schooley RT, Benson CA, Lochhead MJ. Near patient CD4 count in a hospitalized HIV patient population. Cytometry. Part B, Clinical Cytometry. PMID 25917935 DOI: 10.1002/Cyto.B.21248 |
0.377 |
|
| 2015 |
Gois L, Badaró R, Schooley R, Grassi MF. Immune response to Leishmania antigens in an AIDS patient with mucocutaneous leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome (IRIS): a case report. Bmc Infectious Diseases. 15: 38. PMID 25645330 DOI: 10.1186/S12879-015-0774-6 |
0.344 |
|
| 2015 |
Huang ML, Cohen M, Fisher CJ, Schooley RT, Gagneux P, Godula K. Determination of receptor specificities for whole influenza viruses using multivalent glycan arrays. Chemical Communications (Cambridge, England). 51: 5326-9. PMID 25574528 DOI: 10.1039/C4Cc08613A |
0.301 |
|
| 2015 |
Cachay E, Wyles D, Hill L, Ballard C, Torriani F, Colwell B, Kuo A, Schooley R, Mathews WC. The Impact of Direct Acting Antivirals in the Cure of HCV in HIV-Infected Patients With Ongoing Barriers to Care Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1225 |
0.326 |
|
| 2014 |
Li JZ, Heisey A, Ahmed H, Wang H, Zheng L, Carrington M, Wrin T, Schooley RT, Lederman MM, Kuritzkes DR. Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study. Aids (London, England). 28: 2649-57. PMID 25254301 DOI: 10.1097/Qad.0000000000000478 |
0.413 |
|
| 2014 |
Lin JC, Habersetzer F, Rodriguez-Torres M, Afdhal N, Lawitz EJ, Paulson MS, Zhu Y, Subramanian GM, McHutchison JG, Sulkowski M, Wyles DL, Schooley RT. Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response. The Journal of Infectious Diseases. 210: 1881-5. PMID 24907384 DOI: 10.1093/Infdis/Jiu325 |
0.334 |
|
| 2014 |
Orlov M, Vaida F, Williamson K, Deng Q, Smith DM, Duffy PE, Schooley RT. Antigen-presenting phagocytic cells ingest malaria parasites and increase HIV replication in a tumor necrosis factor α-dependent manner. The Journal of Infectious Diseases. 210: 1562-72. PMID 24903666 DOI: 10.1093/Infdis/Jiu317 |
0.686 |
|
| 2014 |
Boltz VF, Bao Y, Lockman S, Halvas EK, Kearney MF, McIntyre JA, Schooley RT, Hughes MD, Coffin JM, Mellors JW. Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP. The Journal of Infectious Diseases. 209: 703-10. PMID 24443547 DOI: 10.1093/Infdis/Jit635 |
0.301 |
|
| 2014 |
Gois LL, Mehta S, Rodrigues MZ, Schooley RT, Badaró R, Grassi MF. Decreased memory T-cell response and function in human immunodeficiency virus-infected patients with tegumentary leishmaniasis. Memã³Rias Do Instituto Oswaldo Cruz. 109: 9-14. PMID 24141962 DOI: 10.1590/0074-0276130174 |
0.378 |
|
| 2013 |
Cohen M, Zhang XQ, Senaati HP, Chen HW, Varki NM, Schooley RT, Gagneux P. Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase. Virology Journal. 10: 321. PMID 24261589 DOI: 10.1186/1743-422X-10-321 |
0.322 |
|
| 2013 |
Chen HW, Cheng JX, Liu MT, King K, Peng JY, Zhang XQ, Wang CH, Shresta S, Schooley RT, Liu YT. Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses. Antiviral Research. 99: 371-82. PMID 23820269 DOI: 10.1016/J.Antiviral.2013.06.014 |
0.317 |
|
| 2013 |
Logan C, Givens M, Ives JT, Delaney M, Lochhead MJ, Schooley RT, Benson CA. Performance evaluation of the MBio Diagnostics point-of-care CD4 counter. Journal of Immunological Methods. 387: 107-13. PMID 23063690 DOI: 10.1016/J.Jim.2012.10.002 |
0.319 |
|
| 2013 |
Saravanan S, Madhavan V, Balakrishnan P, Smith DM, Solomon SS, Sivamalar S, Poongulali S, Kumarasamy N, Schooley RT, Solomon S, Kantor R. Darunavir is a good third-line antiretroviral agent for HIV type 1-infected patients failing second-line protease inhibitor-based regimens in South India. Aids Research and Human Retroviruses. 29: 630-2. PMID 23045961 DOI: 10.1089/Aid.2011.0334 |
0.433 |
|
| 2012 |
Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, Firnhaber C, Grinsztejn B, Hosseinipour MC, Kumwenda J, Lalloo U, Riviere C, Sanchez J, Melo M, Supparatpinyo K, Tripathy S, ... ... Schooley RT, et al. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. Plos Medicine. 9: e1001290. PMID 22936892 DOI: 10.1371/Journal.Pmed.1001290 |
0.325 |
|
| 2012 |
Noormahomed EV, Orlov M, Do Rosario V, Petersen BW, Guthrie C, Badaro R, Schooley RT. A cross-sectional study of sub-clinical plasmodium falciparum infection in HIV-1 infected and uninfected populations in Mozambique, South-Eastern Africa Malaria Journal. 11. PMID 22853699 DOI: 10.1186/1475-2875-11-252 |
0.663 |
|
| 2012 |
Orlov M, Vaida F, Finney OC, Smith DM, Talley AK, Wang R, Kappe SH, Deng Q, Schooley RT, Duffy PE. P. falciparum enhances HIV replication in an experimental malaria challenge system. Plos One. 7: e39000. PMID 22745697 DOI: 10.1371/Journal.Pone.0039000 |
0.672 |
|
| 2012 |
Lockman S, Hughes M, Sawe F, Zheng Y, McIntyre J, Chipato T, Asmelash A, Rassool M, Kimaiyo S, Shaffer D, Hosseinipour M, Mohapi L, Ssali F, Chibowa M, Amod F, ... ... Schooley R, et al. Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. Plos Medicine. 9: e1001236. PMID 22719231 DOI: 10.1371/Journal.Pmed.1001236 |
0.413 |
|
| 2012 |
Li JZ, Brumme CJ, Lederman MM, Brumme ZL, Wang H, Spritzler J, Carrington M, Medvik K, Walker BD, Schooley RT, Kuritzkes DR. Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial. Plos One. 7: e34134. PMID 22479542 DOI: 10.1371/Journal.Pone.0034134 |
0.406 |
|
| 2012 |
Saravanan S, Madhavan V, Kantor R, Sivamalar S, Gomathi S, Solomon SS, Kumarasamy N, Smith DM, Schooley RT, Solomon S, Balakrishnan P. Unusual insertion and deletion at codon 67 and 69 of HIV type 1 subtype C reverse transcriptase among first-line highly active antiretroviral treatment-failing South Indian patients: association with other resistance mutations. Aids Research and Human Retroviruses. 28: 1763-5. PMID 22404052 DOI: 10.1089/Aid.2011.0331 |
0.373 |
|
| 2012 |
Manion M, Rodriguez B, Medvik K, Hardy G, Harding CV, Schooley RT, Pollard R, Asmuth D, Murphy R, Barker E, Brady KE, Landay A, Funderburg N, Sieg SF, Lederman MM. Interferon-alpha administration enhances CD8+ T cell activation in HIV infection. Plos One. 7: e30306. PMID 22291932 DOI: 10.1371/Journal.Pone.0030306 |
0.428 |
|
| 2012 |
Zhu H, Wong-Staal F, Lee H, Syder A, McKelvy J, Schooley RT, Wyles DL. Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals. The Journal of Infectious Diseases. 205: 656-62. PMID 22279172 DOI: 10.1093/Infdis/Jir802 |
0.309 |
|
| 2011 |
Lochhead MJ, Todorof K, Delaney M, Ives JT, Greef C, Moll K, Rowley K, Vogel K, Myatt C, Zhang XQ, Logan C, Benson C, Reed S, Schooley RT. Rapid multiplexed immunoassay for simultaneous serodiagnosis of HIV-1 and coinfections. Journal of Clinical Microbiology. 49: 3584-90. PMID 21865431 DOI: 10.1128/Jcm.00970-11 |
0.403 |
|
| 2011 |
Rodrigues MZ, Grassi MF, Mehta S, Zhang XQ, Gois LL, Schooley RT, Badaro R. Th1/Th2 cytokine profile in patients coinfected with HIV and Leishmania in Brazil. Clinical and Vaccine Immunology : Cvi. 18: 1765-9. PMID 21832098 DOI: 10.1128/Cvi.00076-11 |
0.398 |
|
| 2011 |
Valiaeva N, Wyles DL, Schooley RT, Hwu JB, Beadle JR, Prichard MN, Hostetler KY. Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication. Bioorganic & Medicinal Chemistry. 19: 4616-25. PMID 21719300 DOI: 10.1016/J.Bmc.2011.06.009 |
0.385 |
|
| 2011 |
Li JZ, Brumme ZL, Brumme CJ, Wang H, Spritzler J, Robertson MN, Lederman MM, Carrington M, Walker BD, Schooley RT, Kuritzkes DR. Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial. The Journal of Infectious Diseases. 203: 976-83. PMID 21402549 DOI: 10.1093/Infdis/Jiq143 |
0.454 |
|
| 2011 |
Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, Hecht R, Daar ES, Collier AC, Margolick J, Kilby JM, Routy JP, Conway B, Kaldor J, Levy J, ... Schooley R, et al. Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. The Journal of Infectious Diseases. 203: 442-51. PMID 21245157 DOI: 10.1093/Infdis/Jiq085 |
0.433 |
|
| 2011 |
Valiaeva N, Beadle JR, Wyles DL, Schooley RT, Hostetler KY. Synthesis and Antiviral Activity of 3-Methoxy-2-(phosphonomethoxy)propyl Nucleoside Esters Against HCV and HIV-1 Antiviral Research. 90: A77. DOI: 10.1016/J.Antiviral.2011.03.168 |
0.36 |
|
| 2010 |
Lockman S, Hughes MD, McIntyre J, Zheng Y, Chipato T, Conradie F, Sawe F, Asmelash A, Hosseinipour MC, Mohapi L, Stringer E, Mngqibisa R, Siika A, Atwine D, Hakim J, ... ... Schooley RT, et al. Antiretroviral therapies in women after single-dose nevirapine exposure. The New England Journal of Medicine. 363: 1499-509. PMID 20942666 DOI: 10.1056/Nejmoa0906626 |
0.391 |
|
| 2010 |
Schooley RT, Spritzler J, Wang H, Lederman MM, Havlir D, Kuritzkes DR, Pollard R, Battaglia C, Robertson M, Mehrotra D, Casimiro D, Cox K, Schock B. AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein. The Journal of Infectious Diseases. 202: 705-16. PMID 20662716 DOI: 10.1086/655468 |
0.429 |
|
| 2010 |
Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, ... Schooley RT, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. Jama. 304: 321-33. PMID 20639566 DOI: 10.1001/Jama.2010.1004 |
0.346 |
|
| 2010 |
Borok M, Fiorillo S, Gudza I, Putnam B, Ndemera B, White IE, Gwanzura L, Schooley RT, Campbell TB. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 51: 342-9. PMID 20572760 DOI: 10.1086/654800 |
0.383 |
|
| 2010 |
Asmuth DM, Murphy RL, Rosenkranz SL, Lertora JJ, Kottilil S, Cramer Y, Chan ES, Schooley RT, Rinaldo CR, Thielman N, Li XD, Wahl SM, Shore J, Janik J, Lempicki RA, et al. Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial. The Journal of Infectious Diseases. 201: 1686-96. PMID 20420510 DOI: 10.1086/652420 |
0.427 |
|
| 2010 |
Chen CH, Zhang XQ, Lo CW, Liu PF, Liu YT, Gallo RL, Hsieh MF, Schooley RT, Huang CM. The essentiality of alpha-2-macroglobulin in human salivary innate immunity against new H1N1 swine origin influenza A virus. Proteomics. 10: 2396-401. PMID 20391540 DOI: 10.1002/prca.201090069 |
0.311 |
|
| 2010 |
Monto A, Schooley RT, Lai JC, Sulkowski MS, Chung RT, Pawlotsky JM, McHutchison JG, Jacobson IM. Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop. The American Journal of Gastroenterology. 105: 989-1004; quiz 988, . PMID 20087331 DOI: 10.1038/Ajg.2009.726 |
0.409 |
|
| 2009 |
Kumarasamy N, Madhavan V, Venkatesh KK, Saravanan S, Kantor R, Balakrishnan P, Devaleenal B, Poongulali S, Yepthomi T, Solomon S, Mayer KH, Benson C, Schooley R. High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 306-9. PMID 19522657 DOI: 10.1086/600044 |
0.326 |
|
| 2009 |
DeGruttola V, Little S, Schooley R. Controlling the HIV epidemic, without a vaccine! Aids (London, England). 22: 2554-5. PMID 19005285 DOI: 10.1097/Qad.0B013E32831940D3 |
0.343 |
|
| 2008 |
Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. Jama. 300: 555-70. PMID 18677028 DOI: 10.1001/jama.300.5.555 |
0.346 |
|
| 2008 |
Grant RM, Hamer D, Hope T, Johnston R, Lange J, Lederman MM, Lieberman J, Miller CJ, Moore JP, Mosier DE, Richman DD, Schooley RT, Springer MS, Veazey RS, Wainberg MA. Whither or wither microbicides? Science (New York, N.Y.). 321: 532-4. PMID 18653884 DOI: 10.1126/Science.1160355 |
0.314 |
|
| 2008 |
Smith DM, Schooley RT. Running with scissors: using antiretroviral therapy without monitoring viral load. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 1598-600. PMID 18419496 DOI: 10.1086/587110 |
0.36 |
|
| 2008 |
Wilson CC, Newman MJ, Livingston BD, MaWhinney S, Forster JE, Scott J, Schooley RT, Benson CA. Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy. Clinical and Vaccine Immunology : Cvi. 15: 986-94. PMID 18400976 DOI: 10.1128/Cvi.00492-07 |
0.378 |
|
| 2008 |
Grünberger C, Wyles DL, Kaihara KA, Schooley RT. 3-drug synergistic interactions of small molecular inhibitors of hepatitis C virus replication. The Journal of Infectious Diseases. 197: 42-5. PMID 18171283 DOI: 10.1086/524062 |
0.319 |
|
| 2008 |
Fahey JL, Schooley R. Status of immune-based therapies in HIV infection and AIDS. Clinical and Experimental Immunology. 88: 1-5. PMID 1563093 DOI: 10.1111/J.1365-2249.1992.Tb03029.X |
0.432 |
|
| 2007 |
Al-Harthi L, MaWhinney S, Connick E, Schooley RT, Forster JE, Benson C, Thompson M, Judson F, Palella F, Landay A. Immunophenotypic alterations in acute and early HIV infection. Clinical Immunology (Orlando, Fla.). 125: 299-308. PMID 17916441 DOI: 10.1016/J.Clim.2007.08.011 |
0.395 |
|
| 2007 |
Schooley RT, Mellors JW. No cure yet for HIV-1, but therapeutic research presses on. The Journal of Infectious Diseases. 195: 770-2. PMID 17299705 DOI: 10.1086/511830 |
0.387 |
|
| 2007 |
Sailer CA, Pott GB, Dinarello CA, Whinney SM, Forster JE, Larson-Duran JK, Landay A, Al-Harthi L, Schooley RT, Benson CA, Judson FN, Thompson M, Palella FJ, Shapiro L. Whole-blood interleukin-18 level during early HIV-1 infection is associated with reduced CXCR4 coreceptor expression and interferon- gamma levels. The Journal of Infectious Diseases. 195: 734-8. PMID 17262717 DOI: 10.1086/511435 |
0.406 |
|
| 2007 |
Wyles DL, Kaihara KA, Vaida F, Schooley RT. Synergy of small molecular inhibitors of hepatitis C virus replication directed at multiple viral targets. Journal of Virology. 81: 3005-8. PMID 17182685 DOI: 10.1128/Jvi.02083-06 |
0.336 |
|
| 2006 |
Garcia R, Badaró R, Netto EM, Silva M, Amorin FS, Ramos A, Vaida F, Brites C, Schooley RT. Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients. Aids Research and Human Retroviruses. 22: 1248-52. PMID 17209767 DOI: 10.1089/Aid.2006.22.1248 |
0.384 |
|
| 2006 |
Frey G, Rits-Volloch S, Zhang XQ, Schooley RT, Chen B, Harrison SC. Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion. Proceedings of the National Academy of Sciences of the United States of America. 103: 13938-43. PMID 16963566 DOI: 10.1073/Pnas.0601036103 |
0.34 |
|
| 2006 |
Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. Jama. 296: 827-43. PMID 16905788 DOI: 10.1001/Jama.296.7.827 |
0.416 |
|
| 2006 |
Zhang XQ, Sorensen M, Fung M, Schooley RT. Synergistic in vitro antiretroviral activity of a humanized monoclonal anti-CD4 antibody (TNX-355) and enfuvirtide (T-20). Antimicrobial Agents and Chemotherapy. 50: 2231-3. PMID 16723592 DOI: 10.1128/Aac.00761-05 |
0.349 |
|
| 2004 |
Neid JM, Schooley RT, Campbell TB. Stimulation of Kaposi's sarcoma-associated herpesvirus viremia during hematopoietic stem cell mobilization with filgrastim. American Journal of Hematology. 77: 410-2. PMID 15551282 DOI: 10.1002/Ajh.20175 |
0.326 |
|
| 2004 |
Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. Jama. 292: 251-65. PMID 15249575 DOI: 10.1001/Jama.292.2.251 |
0.431 |
|
| 2004 |
Campbell TB, Rapaport E, Schooley RT, Kuritzkes DR. Increased replication of HIV-1 minor variants during hematopoietic stem-cell mobilization with filgrastim. The Journal of Infectious Diseases. 190: 257-66. PMID 15216459 DOI: 10.1086/421122 |
0.377 |
|
| 2004 |
Schooley RT. Starting highly active antiretroviral therapy for HIV infection: is it WIHS to wait? Annals of Internal Medicine. 140: 305-6. PMID 14970155 DOI: 10.7326/0003-4819-140-4-200402170-00014 |
0.367 |
|
| 2003 |
Garcia R, Schooley RT, Badaró R. An adherence trilogy is essential for long-term HAART success. The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases. 7: 307-14. PMID 14552740 DOI: 10.1590/S1413-86702003000500005 |
0.304 |
|
| 2002 |
Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. Jama. 288: 222-35. PMID 12095387 DOI: 10.1001/Jama.288.2.222 |
0.418 |
|
| 2002 |
Schooley RT, Ruane P, Myers RA, Beall G, Lampiris H, Berger D, Chen SS, Miller MD, Isaacson E, Cheng AK. Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study. Aids (London, England). 16: 1257-63. PMID 12045491 DOI: 10.1097/00002030-200206140-00008 |
0.381 |
|
| 2002 |
Margot NA, Isaacson E, McGowan I, Cheng AK, Schooley RT, Miller MD. Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF. Aids (London, England). 16: 1227-35. PMID 12045487 DOI: 10.1097/00002030-200206140-00004 |
0.405 |
|
| 2001 |
Connick E, Schlichtemeier RL, Purner MB, Schneider KM, Anderson DM, MaWhinney S, Campbell TB, Kuritzkes DR, Douglas JM, Judson FN, Schooley RT. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion. The Journal of Infectious Diseases. 184: 1465-9. PMID 11709791 DOI: 10.1086/324488 |
0.445 |
|
| 2001 |
Schacker T, Little S, Connick E, Gebhard K, Zhang ZQ, Krieger J, Pryor J, Havlir D, Wong JK, Schooley RT, Richman D, Corey L, Haase AT. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. The Journal of Infectious Diseases. 183: 555-62. PMID 11170980 DOI: 10.1086/318524 |
0.405 |
|
| 2000 |
Schooley RT, Spino C, Kuritzkes D, Walker BD, Valentine FA, Hirsch MS, Cooney E, Friedland G, Kundu S, Merigan TC, McElrath MJ, Collier A, Plaeger S, Mitsuyasu R, Kahn J, et al. Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214. The Journal of Infectious Diseases. 182: 1357-64. PMID 11023459 DOI: 10.1086/315860 |
0.432 |
|
| 2000 |
Babiker A, Bartlett J, Breckenridge A, Collins G, Coombs R, Cooper D, Creagh T, Cross A, Daniels M, Darbyshire J, Dawson D, DeGruttola V, DeMasi R, Dolin R, Eron J, ... ... Schooley R, et al. Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis Aids Research and Human Retroviruses. 16: 1123-1133. PMID 10954887 DOI: 10.1089/088922200414965 |
0.343 |
|
| 2000 |
Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. Jama. 283: 381-90. PMID 10647802 DOI: 10.1001/Jama.283.3.381 |
0.401 |
|
| 2000 |
Schooley RT, Mladenovic J, Sevin A, Chiu S, Miles SA, Pomerantz RJ, Campbell TB, Bell D, Ambruso D, Wong R, Landay A, Coombs RW, Fox L, Kamoun M, Jacovini J. Reduced mobilization of CD34+ stem cells in advanced human immunodeficiency virus type 1 disease. The Journal of Infectious Diseases. 181: 148-57. PMID 10608761 DOI: 10.1086/315168 |
0.419 |
|
| 2000 |
Campbell TB, Sevin A, Coombs RW, Peterson GC, Rosandich M, Kuritzkes DR, Mladenovic J, Landay A, Wong R, Ambruso D, Miles S, Pomerantz RJ, Schooley RT. Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Adult AIDS Clinical Trials Group 285 Study Team. Blood. 95: 48-55. PMID 10607683 |
0.368 |
|
| 2000 |
Campbell TB, Sevin A, Coombs RW, Peterson GC, Rosandich M, Kuritzkes DR, Mladenovic J, Landay A, Wong R, Ambruso D, Miles S, Pomerantz RJ, Schooley RT. Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells Blood. 95: 48-55. DOI: 10.1182/Blood.V95.1.48 |
0.463 |
|
| 1999 |
Campbell TB, Fitzpatrick L, MaWhinney S, Zhang X, Schooley RT. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (1999). 22: 333-40. PMID 10634194 DOI: 10.1097/00126334-199912010-00003 |
0.431 |
|
| 1999 |
Haubrich R, Thompson M, Schooley R, Lang W, Stein A, Sereni D, van der Ende ME, Antunes F, Richman D, Pagano G, Kahl L, Fetter A, Brown DJ, Clumeck N. A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team. Aids (London, England). 13: 2411-20. PMID 10597783 DOI: 10.1097/00002030-199912030-00013 |
0.376 |
|
| 1999 |
Zhang XQ, Schooley RT, Gerber JG. The effect of increasing alpha1-acid glycoprotein concentration on the antiviral efficacy of human immunodeficiency virus protease inhibitors. The Journal of Infectious Diseases. 180: 1833-7. PMID 10558938 DOI: 10.1086/315123 |
0.453 |
|
| 1999 |
Schooley RT. Longer-term immunologic effects and side effects of successful antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 29: 12-8. PMID 10433560 DOI: 10.1086/520139 |
0.352 |
|
| 1998 |
Saag MS, Sonnerborg A, Torres RA, Lancaster D, Gazzard BG, Schooley RT, Romero C, Kelleher D, Spreen W, LaFon S. Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults. Abacavir Phase 2 Clinical Team. Aids (London, England). 12: F203-9. PMID 9833848 DOI: 10.1097/00002030-199816000-00002 |
0.419 |
|
| 1998 |
Hughes MD, Daniels MJ, Fischl MA, Kim S, Schooley RT. CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group. Aids (London, England). 12: 1823-32. PMID 9792383 DOI: 10.1097/00002030-199814000-00014 |
0.33 |
|
| 1998 |
Zhang Xq, Fitzpatrick L, Campbell TB, Badaro R, Schechter M, Melo Md, Brites C, Pedral-Sampaio D, Schooley RT. Comparison of the prevalence of antibodies to human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) in Brazil and Colorado. The Journal of Infectious Diseases. 178: 1488-91. PMID 9780272 DOI: 10.1086/314457 |
0.442 |
|
| 1998 |
Mitsuyasu RT, Skolnik PR, Cohen SR, Conway B, Gill MJ, Jensen PC, Pulvirenti JJ, Slater LN, Schooley RT, Thompson MA, Torres RA, Tsoukas CM. Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients. NV15355 Study Team. Aids (London, England). 12: F103-9. PMID 9708399 DOI: 10.1097/00002030-199811000-00001 |
0.408 |
|
| 1998 |
Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. Jama. 280: 78-86. PMID 9660368 DOI: 10.1001/Jama.1997.03540480062040 |
0.449 |
|
| 1998 |
Fitzpatrick LK, Gwanzura L, Zhang X, Mason P, Chikuni O, Schooley R, Katzenstein D. EPIDEMIOLOGIC STUDIES OF HUMAN HERPES VIRUS-8 IN ZIMBABWE. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17: A14. DOI: 10.1097/00042560-199804010-00025 |
0.319 |
|
| 1997 |
Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. Jama. 277: 1962-9. PMID 9200638 |
0.355 |
|
| 1996 |
Connick E, Marr DG, Zhang XQ, Clark SJ, Saag MS, Schooley RT, Curiel TJ. HIV-specific cellular and humoral immune responses in primary HIV infection. Aids Research and Human Retroviruses. 12: 1129-40. PMID 8844017 DOI: 10.1089/Aid.1996.12.1129 |
0.483 |
|
| 1996 |
Schooley RT. Enhancing HIV-1 specific immunity as a therapeutic strategy in AIDS. Advances in Experimental Medicine and Biology. 394: 405-10. PMID 8815705 DOI: 10.1007/978-1-4757-9209-6_37 |
0.442 |
|
| 1996 |
Hammer SM, Katzenstein DA, Hughes MD, Gundacker H, Schooley RT, Haubrich RH, Henry WK, Lederman MM, Phair JP, Niu M, Hirsch MS, Merigan TC. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. The New England Journal of Medicine. 335: 1081-90. PMID 8813038 DOI: 10.1056/Nejm199610103351501 |
0.421 |
|
| 1996 |
Uherova P, Connick E, Mawhinney S, Schlichtemeier R, Schooley RT, Kuritzkes DR. In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative responses from persons infected with human immunodeficiency virus type 1 Journal of Infectious Diseases. 174: 483-489. PMID 8769604 DOI: 10.1093/Infdis/174.3.483 |
0.403 |
|
| 1996 |
Larder BA, Kohli A, Bloor S, Kemp SD, Harrigan PR, Schooley RT, Lange JM, Pennington KN, St Clair MH. Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative Group. Journal of Virology. 70: 5922-9. PMID 8709213 DOI: 10.1128/Jvi.70.9.5922-5929.1996 |
0.405 |
|
| 1996 |
Schooley RT, Campbell TB, Kuritzkes DR, Blaschke T, Stein DS, Rosandich ME, Phair J, Pottage JC, Messari F, Collier A, Kahn J. Phase 1 study of combination therapy with L-697,661 and zidovudine Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12: 363-370. PMID 8673545 DOI: 10.1097/00042560-199608010-00006 |
0.305 |
|
| 1996 |
Schooley RT, Ramirez-Ronda C, Lange JM, Cooper DA, Lavelle J, Lefkowitz L, Moore M, Larder BA, St Clair M, Mulder JW, McKinnis R, Pennington KN, Harrigan PR, Kinghorn I, Steel H, et al. Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group. The Journal of Infectious Diseases. 173: 1354-66. PMID 8648207 DOI: 10.1093/Infdis/173.6.1354 |
0.429 |
|
| 1996 |
Benson EM, French MAH, Schooley RT. 4.2 Immune‐based therapy for HIV infection Medical Journal of Australia. 164: 297-300. DOI: 10.5694/J.1326-5377.1996.Tb94196.X |
0.447 |
|
| 1993 |
Choi S, Lagakos SW, Schooley RT, Volberding PA. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine Annals of Internal Medicine. 118: 674-680. PMID 8096373 DOI: 10.7326/0003-4819-118-9-199305010-00003 |
0.398 |
|
| 1993 |
Ho DD, Cao Y, Zhu T, Farthing C, Wang N, Gu G, Schooley RT, Daar ES. Idiopathic CD4+ T-lymphocytopenia--immunodeficiency without evidence of HIV infection. The New England Journal of Medicine. 328: 380-5. PMID 8093634 DOI: 10.1056/Nejm199302113280602 |
0.42 |
|
| 1993 |
McFarland EJ, Curiel TJ, Schoen DJ, Rosandich ME, Schooley RT, Kuritzkes DR. Cytotoxic T lymphocyte lines specific for human immunodeficiency virus type 1 Gag and reverse transcriptase derived from a vertically infected child. The Journal of Infectious Diseases. 167: 719-23. PMID 7680062 DOI: 10.1093/Infdis/167.3.719 |
0.469 |
|
| 1993 |
Curiel TJ, Wong JT, Gorczyca PF, Schooley RT, Walker BD. CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual. Aids Research and Human Retroviruses. 9: 61-8. PMID 7678973 DOI: 10.1089/Aid.1993.9.61 |
0.439 |
|
| 1993 |
Conway B, Baskar P, Bechtel LJ, Kaplan JC, Hirsch MS, Schooley RT, Pincus SH. Eosinophils as host cells for HIV-1. Archives of Virology. 127: 373-7. PMID 1456897 DOI: 10.1007/Bf01309600 |
0.433 |
|
| 1992 |
Turner S, Tizard R, DeMarinis J, Pepinsky RB, Zullo J, Schooley R, Fisher R. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Proceedings of the National Academy of Sciences of the United States of America. 89: 1335-9. PMID 1741386 DOI: 10.1073/Pnas.89.4.1335 |
0.406 |
|
| 1992 |
Leff JA, Oppegard MA, Curiel TJ, Brown KS, Schooley RT, Repine JE. Progressive increases in serum catalase activity in advancing human immunodeficiency virus infection. Free Radical Biology & Medicine. 13: 143-9. PMID 1516841 DOI: 10.1016/0891-5849(92)90076-S |
0.403 |
|
| 1992 |
Zhang XQ, Yang L, Ho DD, Kuritzkes DR, Chen IS, Ching WT, Chen YM, Schooley RT. Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping. The Journal of Infectious Diseases. 165: 805-12. PMID 1373751 DOI: 10.1093/Infdis/165.5.805 |
0.33 |
|
| 1991 |
Conway B, Tomford W, Mankin HJ, Hirsch MS, Schooley RT. Radiosensitivity of HIV-1--potential application to sterilization of bone allografts. Aids (London, England). 5: 608-9. PMID 1863419 DOI: 10.1097/00002030-199105000-00029 |
0.343 |
|
| 1991 |
Goldfeld AE, Birch-Limberger K, Schooley RT, Walker BD. HIV-1 Infection Does Not Induce Tumor Necrosis Factor-?? or Interferon-?? Gene Transcription Jaids Journal of Acquired Immune Deficiency Syndromes. 4: 41???47. DOI: 10.1097/00126334-199101000-00006 |
0.397 |
|
| 1990 |
Chernow B, Schooley RT, Dracup K, Napolitano LM, Stanford GG, Klibanski A. Serum prolactin concentrations in patients with the acquired immunodeficiency syndrome. Critical Care Medicine. 18: 440-1. PMID 2318055 DOI: 10.1097/00003246-199004000-00019 |
0.397 |
|
| 1990 |
Schooley RT, Merigan TC, Gaut P, Hirsch MS, Holodniy M, Flynn T, Liu S, Byington RE, Henochowicz S, Gubish E. Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial. Annals of Internal Medicine. 112: 247-53. PMID 2297203 DOI: 10.7326/0003-4819-112-4-247 |
0.405 |
|
| 1990 |
Schooley RT. Cytomegalovirus in the setting of infection with human immunodeficiency virus. Reviews of Infectious Diseases. S811-9. PMID 2173110 DOI: 10.1093/Clinids/12.Supplement_7.S811 |
0.482 |
|
| 1989 |
Johnson VA, Barlow MA, Chou TC, Fisher RA, Walker BD, Hirsch MS, Schooley RT. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine. The Journal of Infectious Diseases. 159: 837-44. PMID 2785146 DOI: 10.1093/Infdis/159.5.837 |
0.467 |
|
| 1989 |
Merigan TC, Skowron G, Bozzette SA, Richman D, Uttamchandani R, Fischl M, Schooley R, Hirsch M, Soo W, Pettinelli C. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study. Annals of Internal Medicine. 110: 189-94. PMID 2536257 DOI: 10.7326/0003-4819-110-3-189 |
0.38 |
|
| 1989 |
Walker BD, Flexner C, Birch-Limberger K, Fisher L, Paradis TJ, Aldovini A, Young R, Moss B, Schooley RT. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1 Proceedings of the National Academy of Sciences of the United States of America. 86: 9514-9518. PMID 2480604 DOI: 10.1073/Pnas.86.23.9514 |
0.426 |
|
| 1989 |
Schooley RT. Epstein—Barr virus Current Opinion in Infectious Diseases. 2: 267-271. DOI: 10.1097/00001432-198904000-00018 |
0.312 |
|
| 1988 |
Gibas A, Dienstag JL, Schafer AI, Delmonico F, Bynum TE, Schooley R, Rubin RH, Cosimi AB. Cure of hemophilia A by orthotopic liver transplantation. Gastroenterology. 95: 192-4. PMID 3131178 DOI: 10.1016/0016-5085(88)90310-1 |
0.305 |
|
| 1988 |
D'amico DJ, Skolnik PR, Kosloff BR, Pinkston P, Hirsch MS, Schooley RT. Resolution of Cytomegalovirus Retinitis with Zidovudine Therapy Archives of Ophthalmology. 106: 1168-1169. PMID 2843155 DOI: 10.1001/Archopht.1988.01060140328016 |
0.378 |
|
| 1988 |
Vogt MW, Durno AG, Chou TC, Coleman LA, Paradis TJ, Schooley RT, Kaplan JC, Hirsch MS. Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1. The Journal of Infectious Diseases. 158: 378-85. PMID 2841378 DOI: 10.1093/Infdis/158.2.378 |
0.405 |
|
| 1988 |
de la Monte SM, Gabuzda DH, Ho DD, Brown RH, Hedley-Whyte ET, Schooley RT, Hirsch MS, Bhan AK. Peripheral neuropathy in the acquired immunodeficiency syndrome. Annals of Neurology. 23: 485-92. PMID 2839106 DOI: 10.1002/Ana.410230510 |
0.364 |
|
| 1988 |
Fisher RA, Bertonis JM, Meier W, Johnson VA, Costopoulos DS, Liu T, Tizard R, Walker BD, Hirsch MS, Schooley RT. HIV infection is blocked in vitro by recombinant soluble CD4. Nature. 331: 76-8. PMID 2829022 DOI: 10.1038/331076A0 |
0.449 |
|
| 1988 |
Walker BD, Flexner C, Paradis TJ, Fuller TC, Hirsch MS, Schooley RT, Moss B. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals Science. 240: 64-66. PMID 2451288 DOI: 10.1126/Science.2451288 |
0.46 |
|
| 1988 |
Schooley RT. Chronic Epstein-Barr virus infection tired terminology for an unrelated phenomenon Clinical Microbiology Newsletter. 10: 161-164. DOI: 10.1016/0196-4399(88)90023-2 |
0.354 |
|
| 1988 |
Schooley RT. Waltzing HIV-tilda Archives of Internal Medicine. 148: 778. DOI: 10.1001/Archinte.1988.00380040018003 |
0.458 |
|
| 1987 |
Kaplan JC, Crawford DC, Durno AG, Schooley RT. Inactivation of human immunodeficiency virus by Betadine. Infection Control : Ic. 8: 412-4. PMID 3667119 DOI: 10.1017/S0195941700066583 |
0.465 |
|
| 1987 |
Sibinga CT, de Vries B, McShine RL, Das PC, Schooley RT. HIV antibody screening in a low-risk population (blood donors) Transfusion. 27: 215-6. PMID 3644578 DOI: 10.1046/J.1537-2995.1987.27287150209.X |
0.339 |
|
| 1987 |
Vogt MW, Witt DJ, Craven DE, Byington R, Crawford DF, Hutchinson MS, Schooley RT, Hirsch MS. Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Annals of Internal Medicine. 106: 380-2. PMID 3643769 DOI: 10.7326/0003-4819-106-3-380 |
0.395 |
|
| 1987 |
de la Monte SM, Ho DD, Schooley RT, Hirsch MS, Richardson EP. Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology. 37: 562-9. PMID 3561770 DOI: 10.1212/Wnl.37.4.562 |
0.351 |
|
| 1987 |
Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature. 328: 345-8. PMID 3496541 DOI: 10.1038/328345A0 |
0.484 |
|
| 1987 |
Pomerantz RJ, Kuritzkes DR, de la Monte SM, Rota TR, Baker AS, Albert D, Bor DH, Feldman EL, Schooley RT, Hirsch MS. Infection of the retina by human immunodeficiency virus type I. The New England Journal of Medicine. 317: 1643-7. PMID 3479685 DOI: 10.1056/Nejm198712243172607 |
0.469 |
|
| 1987 |
Blumberg RS, Paradis T, Hartshorn KL, Vogt M, Ho DD, Hirsch MS, Leban J, Sato VL, Schooley RT. Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus. The Journal of Infectious Diseases. 156: 878-84. PMID 3479500 DOI: 10.1093/Infdis/156.6.878 |
0.479 |
|
| 1987 |
Hartshorn KL, Vogt MW, Chou TC, Blumberg RS, Byington R, Schooley RT, Hirsch MS. Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon. Antimicrobial Agents and Chemotherapy. 31: 168-72. PMID 3471180 DOI: 10.1128/Aac.31.2.168 |
0.343 |
|
| 1987 |
Blumberg RS, Hartshorn KL, Ardman B, Kaplan JC, Paradis T, Vogt M, Hirsch MS, Schooley RT. Dot immunobinding assay for detection of human immunodeficiency virus-associated antigens. Journal of Clinical Microbiology. 25: 1989-92. PMID 3312291 DOI: 10.1128/Jcm.25.10.1989-1992.1987 |
0.431 |
|
| 1987 |
Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. The New England Journal of Medicine. 317: 185-91. PMID 3299089 DOI: 10.1056/Nejm198707233170401 |
0.316 |
|
| 1987 |
Hartshorn KL, Neumeyer D, Vogt MW, Schooley RT, Hirsch MS. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. Aids Research and Human Retroviruses. 3: 125-33. PMID 3113463 DOI: 10.1089/Aid.1987.3.125 |
0.397 |
|
| 1987 |
Wong KW, Hedges TR, D'amico DJ, Kenyon KR, Soong HK, Schooley RT. Ocular Involvement Associated With Chronic Epstein-Barr Virus Disease Archives of Ophthalmology. 105: 788-792. PMID 3034222 DOI: 10.1001/Archopht.1987.01060060074036 |
0.352 |
|
| 1987 |
Blumberg RS, Paradis T, Byington R, Henle W, Hirsch MS, Schooley RT. Effects of human immunodeficiency virus on the cellular immune response to Epstein-Barr virus in homosexual men: characterization of the cytotoxic response and lymphokine production. The Journal of Infectious Diseases. 155: 877-90. PMID 3031170 DOI: 10.1093/Infdis/155.5.877 |
0.417 |
|
| 1987 |
Blumberg RS, Paradis TJ, Crawford D, Byington RE, Hirsch MS, Schooley RT. Effects of human immunodeficiency virus (HIV) on the cytotoxic response to Epstein Barr virus (EBV) transformed B lymphocytes. Aids Research and Human Retroviruses. 3: 303-15. PMID 2829951 DOI: 10.1089/Aid.1987.3.303 |
0.463 |
|
| 1987 |
Vogt MW, Hartshorn KL, Furman PA, Chou TC, Fyfe JA, Coleman LA, Crumpacker C, Schooley RT, Hirsch MS. Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science (New York, N.Y.). 235: 1376-9. PMID 2435003 DOI: 10.1126/Science.2435003 |
0.417 |
|
| 1987 |
Ho DD, Sarngadharan MG, Hirsch MS, Schooley RT, Rota TR, Kennedy RC, Chanh TC, Sato VL. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. Journal of Virology. 61: 2024-2028. DOI: 10.1128/Jvi.61.6.2024-2028.1987 |
0.34 |
|
| 1987 |
Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS. Isolation of HTLV-III from CSF and neural tissues of patients with AIDS-related neurological syndromes Annales De L'Institut Pasteur Virology. 138: 137-144. DOI: 10.1016/S0769-2617(87)80086-2 |
0.304 |
|
| 1987 |
Pomerantz RJ, Schooley RT. Therapy of Human Immunodeficiency Virus Infections Clinics in Laboratory Medicine. 7: 793-813. DOI: 10.1016/S0272-2712(18)30717-0 |
0.438 |
|
| 1986 |
Hartshorn KL, Sandstrom EG, Neumeyer D, Paradis TJ, Chou TC, Schooley RT, Hirsch MS. Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon. Antimicrobial Agents and Chemotherapy. 30: 189-91. PMID 3019235 DOI: 10.1128/Aac.30.1.189 |
0.313 |
|
| 1986 |
Sandstrom EG, Andrews C, Schooley RT, Byington R, Hirsch MS. Suppression of concanavalin A-induced blastogenesis by HTLV-III-infected H9 cells. Clinical Immunology and Immunopathology. 40: 253-8. PMID 3013473 DOI: 10.1016/0090-1229(86)90028-0 |
0.344 |
|
| 1986 |
Schooley RT, Carey RW, Miller G, Henle W, Eastman R, Mark EJ, Kenyon K, Wheeler EO, Rubin RH. Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Annals of Internal Medicine. 104: 636-43. PMID 3008616 DOI: 10.7326/0003-4819-104-5-636 |
0.376 |
|
| 1986 |
Blumberg RS, Sandstrom EG, Paradis TJ, Neumeyer DN, Sarngadharan MG, Hartshorn KL, Byington RE, Hirsch MS, Schooley RT. Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence. Journal of Clinical Microbiology. 23: 1072-7. PMID 2423552 DOI: 10.1128/Jcm.23.6.1072-1077.1986 |
0.311 |
|
| 1985 |
Felsenstein D, D'Amico DJ, Hirsch MS, Neumeyer DA, Cederberg DM, de Miranda P, Schooley RT. Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl] guanine Annals of Internal Medicine. 103: 377-380. PMID 2992334 DOI: 10.7326/0003-4819-103-3-377 |
0.312 |
|
| 1985 |
Sandstrom EG, Schooley RT, Ho DD, Byington R, Sarngadharan MG, MacLane ME, Essex M, Gallo RC, Hirsch MS. Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion. 25: 308-12. PMID 2992128 DOI: 10.1046/J.1537-2995.1985.25485273806.X |
0.307 |
|
| 1985 |
Edson CM, Hosler BA, Poodry CA, Schooley RT, Waters DJ, Thorley-Lawson DA. Varicella-zoster virus envelope glycoproteins: biochemical characterization and identification in clinical material. Virology. 145: 62-71. PMID 2990103 DOI: 10.1016/0042-6822(85)90201-6 |
0.303 |
|
| 1985 |
Miller G, Grogan E, Fischer DK, Niederman JC, Schooley RT, Henle W, Lenoir G, Liu CR. Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer. The New England Journal of Medicine. 312: 750-5. PMID 2983211 DOI: 10.1056/Nejm198503213121204 |
0.304 |
|
| 1985 |
Hirsch MS, Wormser GP, Schooley RT, Ho DD, Felsenstein D, Hopkins CC, Joline C, Duncanson F, Sarngadharan MG, Saxinger C. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III). The New England Journal of Medicine. 312: 1-4. PMID 2981106 DOI: 10.1056/Nejm198501033120101 |
0.358 |
|
| 1985 |
Ho DD, Hartshorn KL, Rota TR, Andrews CA, Kaplan JC, Schooley RT, Hirsch MS. Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. Lancet (London, England). 1: 602-4. PMID 2857946 DOI: 10.1016/S0140-6736(85)92144-0 |
0.328 |
|
| 1984 |
Schooley RT, Densen P, Harmon D, Felsenstein D, Hirsch MS, Henle W, Weitzman S. Antineutrophil antibodies in infectious mononucleosis. The American Journal of Medicine. 76: 85-90. PMID 6318560 DOI: 10.1016/0002-9343(84)90754-X |
0.32 |
|
| 1984 |
Ho DD, Schooley RT, Rota TR, Kaplan JC, Flynn T, Salahuddin SZ, Gonda MA, Hirsch MS. HTLV-III in the semen and blood of a healthy homosexual man. Science (New York, N.Y.). 226: 451-3. PMID 6208608 DOI: 10.1126/Science.6208608 |
0.337 |
|
| 1984 |
Hirsch MS, Schooley RT, Ho DD, Kaplan JC. Possible viral interactions in the acquired immunodeficiency syndrome (AIDS). Reviews of Infectious Diseases. 6: 726-31. PMID 6095405 DOI: 10.1093/Clinids/6.5.726 |
0.338 |
|
| 1983 |
Hochberg FH, Miller G, Schooley RT, Hirsch MS, Feorino P, Henle W. Central-nervous-system lymphoma related to Epstein-Barr virus. The New England Journal of Medicine. 309: 745-8. PMID 6310394 DOI: 10.1056/Nejm198309293091301 |
0.347 |
|
| 1983 |
Schooley RT, Hirsch MS, Colvin RB, Cosimi AB, Tolkoff-Rubin NE, McCluskey RT, Burton RC, Russell PS, Herrin JT, Delmonico FL, Giorgi JV, Henle W, Rubin RH. Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. The New England Journal of Medicine. 308: 307-13. PMID 6296673 DOI: 10.1056/Nejm198302103080603 |
0.331 |
|
| 1983 |
Thorley-Lawson DA, Schooley RT, Bhan AK, Nadler LM. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell. 30: 415-25. PMID 6291768 DOI: 10.1016/0092-8674(82)90239-2 |
0.313 |
|
| 1983 |
Hirsch MS, Schooley RT. Drug therapy. Treatment of herpesvirus infections. The New England Journal of Medicine. 309: 963-70. PMID 6194435 DOI: 10.1056/Nejm198310203091607 |
0.354 |
|
| 1982 |
Geraci JR, St Aubin DJ, Barker IK, Webster RG, Hinshaw VS, Bean WJ, Ruhnke HL, Prescott JH, Early G, Baker AS, Madoff S, Schooley RT. Mass mortality of harbor seals: pneumonia associated with influenza A virus. Science (New York, N.Y.). 215: 1129-31. PMID 7063847 DOI: 10.1126/Science.7063847 |
0.327 |
|
| 1981 |
Rubin RH, Carney WP, Schooley RT, Colvin RB, Burton RC, Hoffman RA, Hansen WP, Cosimi AB, Russell PS, Hirsch MS. The effect of infection on T lymphocyte subpopulations: a preliminary report. International Journal of Immunopharmacology. 3: 307-12. PMID 6270027 DOI: 10.1016/0192-0561(81)90024-2 |
0.365 |
|
| 1981 |
Schooley RT, Haynes BF, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS. Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation. Cellular Immunology. 56: 518-25. PMID 6258810 DOI: 10.1016/0008-8749(80)90126-4 |
0.329 |
|
| 1981 |
Schooley R, Haynes B, Grouse J, Payling-Wright C, Fauci A, Dolin R. Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems Blood. 57: 510-517. DOI: 10.1182/Blood.V57.3.510.Bloodjournal573510 |
0.309 |
|
| Show low-probability matches. |